GALT Cash Flow Breakdown | GALECTIN THERAPEUTICS INC.

GALECTIN THERAPEUTICS INC. Cash Flow Breakdown

Cash flow breakdown shows where GALECTIN THERAPEUTICS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $23.88M went out.
Fiscal year ended 2025-12-31: from investing, $0.00 came in.
Fiscal year ended 2025-12-31: from financing, $26.48M came in.
Fiscal year ended 2025-12-31: change in cash, $2.60M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Commercial paper	New shares sold	Other	Not split out	Change in cash
2025-12-31	-$23.88M	$0.00	$21.00M	$3.23M		$2.24M*	$2.60M
2024-12-31	-$41.77M	$0.00	$30.00M	$0.00		$1.23M*	-$10.54M
2023-12-31	-$32.97M	$0.00	$30.00M			$10.03M*	$7.07M
2022-12-31	-$31.06M	$0.00	$10.00M	$0.00			-$21.06M
2021-12-31	-$24.31M	$0.00	$0.00	$6.81M		$30.00M*	$12.51M
2020-12-31	-$20.60M	$0.00		$263.00K			-$20.34M
2019-12-31	-$10.85M			$50.47M			$39.23M
2018-12-31	-$10.18M	$0.00		$15.38M			$5.20M
2017-12-31	-$15.89M	$0.00		$3.58M			-$12.31M
2016-12-31	-$16.41M	$0.00		$5.92M			-$10.48M
2015-12-31	-$16.98M	$0.00		$13.70M			-$3.28M
2014-12-31	-$12.43M	-$400.00K		$29.34M		$2.13M*	$18.64M
2013-12-31	-$7.48M	$0.00*		$3.83M	$0.00*	$4.78M*	$1.13M
2012-12-31	-$7.50M	$64.00K		$10.40M			$2.97M
2011-12-31	-$5.68M	-$15.00K		$234.00K		$5.96M*	$506.00K
2010-12-31	-$3.10M					$8.74M*	$5.64M

Each quarter (3 month)

Quarter end	Running the business	From investing	Commercial paper	New shares sold	Other	Not split out	Change in cash
2026-06-30	-$2.44M*		-$257.00K*			$1.85M*
2026-03-31	-$3.87M		$257.00K				-$3.61M
2025-12-31	-$6.04M*		$10.00M*	$1.16M*		$1.07M*
2025-09-30	-$3.54M*		$0.00*	$853.00K*
2025-06-30	-$6.60M*		$11.00M*			$1.94M*
2025-03-31	-$7.69M		$0.00				-$7.69M
2024-12-31	-$12.79M*		$0.00*	$0.00*		$851.00K*
2024-09-30	-$8.54M*		$10.00M*	$0.00*
2024-06-30	-$8.33M*		$10.00M*
2024-03-31	-$12.11M		$10.00M				-$2.10M
2023-12-31	-$4.70M*		$10.00M*
2023-09-30	-$7.64M*		$0.00*			$10.03M*
2023-06-30	-$9.83M*		$10.00M*
2023-03-31	-$10.79M		$10.00M				-$793.00K
2022-12-31	-$7.24M*		$10.00M*	$0.00*
2022-09-30	-$8.35M*		$0.00*	$0.00*
2022-06-30	-$7.43M*		$0.00*	$0.00*
2022-03-31	-$8.04M		$0.00	$0.00			-$8.04M
2021-12-31	-$6.95M*			-$1.00K*		$10.00M*
2021-09-30	-$5.00M*			$0.00*		$10.00M*
2021-06-30	-$5.98M*			$6.82M*		$10.00M*
2021-03-31	-$6.38M			$0.00			-$6.38M
2020-12-31	-$5.41M*			$0.00*
2020-09-30	-$8.21M*			$0.00*
2020-06-30	-$2.60M*			$44.00K*
2020-03-31	-$4.37M			$219.00K			-$4.15M
2019-12-31	-$3.76M*			$902.00K*
2019-09-30	-$1.48M*			$163.00K*
2019-06-30	-$2.33M*			$47.40M*			$45.07M*
2019-03-31	-$3.28M			$2.00M			-$1.28M
2018-12-31	-$2.01M*			$124.00K*			-$1.88M*
2018-09-30	-$1.58M*			$1.22M*			-$361.00K*
2018-06-30	-$3.08M*			$9.59M*			$6.51M*
2018-03-31	-$3.52M			$4.45M			$935.00K
2017-12-31	-$3.90M*			-$1.00K*			-$3.90M*
2017-09-30	-$3.12M*			$954.00K*			-$2.17M*
2017-06-30	-$5.00M*			$485.00K*			-$4.52M*
2017-03-31	-$3.86M			$2.15M			-$1.72M
2016-12-31	-$4.87M*	$0.00*		$5.67M*		-$1.50M*	-$697.00K*
2016-09-30	-$3.44M*	$0.00*		$0.00*		$1.50M*	-$1.94M*
2016-06-30	-$4.61M*	$0.00*					-$4.35M*
2016-03-31	-$3.49M	$0.00					-$3.49M
2015-12-31	-$4.60M*	$0.00*		$9.13M*			$4.53M*
2015-09-30	-$5.08M*	$0.00*		$41.00K*			-$5.04M*
2015-06-30	-$2.99M*	$0.00*		$0.00*			-$2.99M*
2015-03-31	-$4.31M	$0.00		$4.53M			$221.00K
2014-12-31	-$3.11M*	$0.00*		$1.10M*			-$2.07M*
2014-09-30	-$3.28M*	$0.00*		$60.00K*			-$3.22M*
2014-06-30	-$2.41M*	$0.00*		$0.00*			-$2.17M*
2014-03-31	-$3.62M	-$400.00K		$28.18M	$0.00*	$1.95M*	$26.11M
2013-12-31	-$1.65M*	$0.00*		$833.00K*	$0.00*	$1.59M*	$774.00K*
2013-09-30	-$1.48M*	$0.00*		$3.00M*	$0.00*	$3.10M*	$4.62M*
2013-06-30	-$1.93M*	$0.00*		$0.00*	$0.00*		-$1.92M*
2013-03-31	-$2.42M	$0.00*		$0.00*	$0.00*		-$2.35M
2012-12-31	-$1.75M*	$56.00K*		$0.00*			-$1.70M*
2012-09-30	-$2.08M*	$8.00K*		$0.00*	$0.00*		-$2.07M*
2012-06-30	-$2.18M*	$0.00*		$0.00*	$0.00*		-$2.18M*
2012-03-31	-$1.49M	$0.00*		$10.40M	$0.00*		$8.92M
2011-12-31	-$1.54M*	-$5.00K*			$0.00*		-$1.55M*
2011-09-30	-$1.25M*	-$5.00K*			$0.00*	$1.22M*	-$40.00K*
2011-06-30	-$1.52M*					$2.56M*	$1.04M*
2011-03-31	-$1.37M					$2.42M*	$1.06M
2010-12-31	-$583.00K*					$3.66M*	$3.08M*
2010-09-30	-$827.00K*					$778.00K*	-$49.00K*

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63